| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| UNIVERSAL INSURANCE HOLDINGS, INC. | Director | Common Stock | 13.9K | $259K | $18.62 | Jun 13, 2024 | Direct |
| Clarus Therapeutics Holdings, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 140K | Dec 11, 2021 | Direct | ||
| Clarus Therapeutics Holdings, Inc. | Chief Financial Officer | Common Stock | 55.8K | Dec 11, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| UVE | UNIVERSAL INSURANCE HOLDINGS, INC. | Jun 13, 2024 | 1 | $65K | 4 | Jun 17, 2024 | Director |
| UVE | UNIVERSAL INSURANCE HOLDINGS, INC. | Jun 20, 2023 | 1 | $0 | 4 | Jun 22, 2023 | Director |
| UVE | UNIVERSAL INSURANCE HOLDINGS, INC. | Sep 29, 2022 | 1 | $10K | 4 | Oct 3, 2022 | Director |
| UVE | UNIVERSAL INSURANCE HOLDINGS, INC. | Jun 10, 2022 | 1 | $0 | 4 | Jun 14, 2022 | Director |
| CRXT | Clarus Therapeutics Holdings, Inc. | Dec 11, 2021 | 2 | $0 | 4 | Dec 14, 2021 | Chief Financial Officer |
| CRXT | Clarus Therapeutics Holdings, Inc. | Sep 9, 2021 | 0 | $0 | 3 | Sep 13, 2021 | Chief Financial Officer |